Biomea Fusion, Inc. (BMEA) revenue by segment

BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$0.58+0.02 (+3.47%)

Close on Nov 13, 2026Market cap $42.20MP/E –Yield –

Biomea Fusion, Inc. revenue by segment

Biomea Fusion does not break out revenue by segment, region or product in the tagged data of its filings for this period type.

See a number that looks wrong?